Neurotech International (ASX:NTI) Gets FDA Green Light to Start US Trials
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDNeurologySafetyPolicyIndustryMental Health Why This Matters Clinicians need to understand that FDA clearance…
Clinical Trial: THC-CBD Formulation Reduces Agitation in Dementia Patients, With Nearly …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyTHCCBDAgingMental HealthSafety Why This Matters This trial provides clinical evidence that a THC-CBD…
Unbox
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchHempCBDTHCSafetyIndustry Dr. Caplan's Take I appreciate the question, but the article summary…
India Approves World’s First Synthetic CBD Therapy For Anxiety Disorders
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDAnxietyMental HealthPolicyResearchSafetyNeurology Why This Matters India's approval of synthetic CBD as a…
THC/CBD Shows Promise for Treating Agitation in Late-Stage Alzheimer’s
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyTHCCBDAgingResearchMental HealthSafety Why This Matters Clinicians managing behavioral symptoms in advanced…
Study Suggests Medical Cannabis Eases Dementia Agitation
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCCBDNeurologyAgingMental HealthSafety Why This Matters Clinicians treating dementia patients with behavioral…
Nine out of 10 elderly dementia sufferers become less agitated after marijuana treatment, study finds
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AgingNeurologyResearchMental HealthCBDSafetyAnxiety Why This Matters Clinicians treating agitation in elderly dementia…
Medical cannabis may help agitation in dementia, study suggests
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyMental HealthAgingResearchTHCCBDAnxiety Why This Matters Dementia-related agitation is a significant clinical…
Artelo Biosciences Announces ART27.13 Data Suggest Potential Benefit for Neuropathic …
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainNeurologyResearchSafetyCBDAnxietyMental Health Why This Matters ART27.13's selective peripheral cannabinoid…
Understanding alcohol, cannabis use in pregnancy and postpartum in people with HIV
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyMental HealthPediatricsPolicyAnxietyCBD Why This Matters Clinicians treating pregnant and postpartum people…
